The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
Open accessAbstract
Diffuse intrinsic pontine glioma (DIPG) is the most severe paediatric solid tumour, with no significant therapeutic progress made in the past 50 years. Recent studies suggest that diffuse midline glioma, H3-K27M mutant, may comprise more than one biological entity. The aim of the study was to determine the clinical and biological variables that most impact their prognosis. Ninety-one patients with classically defined DIPG underwent a systematic stereotactic biopsy and were included in this observational retrospective study. Histone H3 genes mutations were assessed by immunochemistry and direct sequencing, whilst global gene expression profiling and chromosomal imbalances were determined by microarrays. A full description of the MRI findings at diagnosis and at relapse was integrated with the molecular profiling data and clinical outcome. All DIPG but one were found to harbour either a somatic H3-K27M mutation and/or loss of H3K27 trimethylation. We also discovered a novel K27M mutation in HIST2H3C, and a lysine-to-isoleucine substitution (K27I) in H3F3A, also creating a loss of trimethylation. Patients with tumours harbouring a K27M mutation in H3.3 (H3F3A) did not respond clinically to radiotherapy as well, relapsed significantly earlier and exhibited more metastatic recurrences than those in H3.1 (HIST1H3B/C). H3.3-K27M-mutated DIPG have a proneural/oligodendroglial phenotype and a pro-metastatic gene expression signature with PDGFRA activation, while H3.1-K27M-mutated tumours exhibit a mesenchymal/astrocytic phenotype and a pro-angiogenic/hypoxic signature supported by expression profiling and radiological findings. H3K27 alterations appear as the founding event in DIPG and the mutations in the two main histone H3 variants drive two distinct oncogenic programmes with potential specific therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575 · cited 7×
“a Statistical significant enrichment of mesenchymal-like glioblastoma multiforme (GBM) [57] and astroglia [9] signatures was found in H3.”
BackgroundInfluentialHypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Calamita, E., Schmid, M., Kunz, M., Ndebele-Murisa, M. R., Magadza, C. H. D., Nyambe, I., & Wehrli, B. (2019) · Figshare · doi:10.26181/6153922fe919c · Cited by 4,222
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129 · cited 4×
“1-mutated tumours, we identified the overexpression of genes linked to the mesenchymal glioblastoma subtype [21, 57] and astroglial cells [9] (Figs.”
BackgroundInfluentialDriver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631 · cited 1×
“A unique epigenetic reprogramming has recently been suggested in pHGG by the discovery of recurrent mutations in genes encoding histone H3 variants, never described in any other type of cancer of any location or age [50, 59].”
BackgroundCircular binary segmentation for the analysis of array-based DNA copy number data
Olshen, A. B., Venkatraman, E. S., Lucito, R., & Wigler, M. (2004) · Biostatistics · doi:10.1093/biostatistics/kxh008 · Cited by 2,325
Endogenous human microRNAs that suppress breast cancer metastasis
Tavazoie, S. F., Alarcón, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,857
Sturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.-A., Jones, D. T. W., Konermann, C., Pfaff, E., Tönjes, M., Sill, M., Bender, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.024 · Cited by 1,828
St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2012) · Nature Genetics · doi:10.1038/ng.1102 · Cited by 1,724
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Lewis, P. W., Müller, M. M., Koletsky, M. S., Cordero, F., Lin, S., Banaszynski, L. A., Garcia, B. A., Muir, T. W., Becher, O. J., & Allis, C. D. (2013) · Science · doi:10.1126/science.1232245 · Cited by 1,345 · cited 14×
“Loss of H3K27me3 as a defining characteristic of DIPG.”
BackgroundInfluentialDistinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions
Goldberg, A. D., Banaszynski, L. A., Noh, K.-M., Lewis, P. W., Elsaesser, S. J., Stadler, S., Dewell, S., Law, M., Guo, X., Li, X., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.003 · Cited by 1,280
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
Manalo, D. J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B. D., Ye, S. Q., Garcia, J. G. N., & Semenza, G. L. (2005) · Blood · doi:10.1182/blood-2004-07-2958 · Cited by 1,154
the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2014) · Nature Genetics · doi:10.1038/ng.2938 · Cited by 1,105
Khuong-Quang, D.-A., Buczkowicz, P., Rakopoulos, P., Liu, X.-Y., Fontebasso, A. M., Bouffet, E., Bartels, U., Albrecht, S., Schwartzentruber, J., Letourneau, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0998-0 · Cited by 1,028 · cited 3×
“We show here that the H3-K27M-mutated DIPG group recognized by previous studies [7, 8, 31] could be further divided into two subgroups, H3.”
BackgroundResultA neurocentric perspective on glioma invasion
Cuddapah, V. A., Robel, S., Watkins, S., & Sontheimer, H. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3765 · Cited by 831
Bender, S., Tang, Y., Lindroth, A. M., Hovestadt, V., Jones, D. T. W., Kool, M., Zapatka, M., Northcott, P. A., Sturm, D., Wang, W., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.006 · Cited by 818
Self-citationGene Expression Profiling of Gliomas Strongly Predicts Survival
Freije, W. A., Castro-Vargas, F. E., Fang, Z., Horvath, S., Cloughesy, T., Liau, L. M., Mischel, P. S., & Nelson, S. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0452 · Cited by 744
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
Chan, K.-M., Fang, D., Gan, H., Hashizume, R., Yu, C., Schroeder, M., Gupta, N., Mueller, S., James, C. D., Jenkins, R., et al. (2013) · Genes & Development · doi:10.1101/gad.217778.113 · Cited by 707
Paugh, B. S., Qu, C., Jones, C., Liu, Z., Adamowicz-Brice, M., Zhang, J., Bax, D. A., Coyle, B., Barrow, J., Hargrave, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7252 · Cited by 654
Self-citationBuczkowicz, P., Hoeman, C., Rakopoulos, P., Pajovic, S., Letourneau, L., Dzamba, M., Morrison, A., Lewis, P., Bouffet, E., Bartels, U., et al. (2014) · Nature Genetics · doi:10.1038/ng.2936 · Cited by 647
Self-citationChen, C., Grennan, K., Badner, J., Zhang, D., Gershon, E., Jin, L., & Liu, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017238 · Cited by 542
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Taylor, K. R., Mackay, A., Truffaux, N., Butterfield, Y. S., Morozova, O., Philippe, C., Castel, D., Grasso, C. S., Vinci, M., Carvalho, D., et al. (2014) · Nature Genetics · doi:10.1038/ng.2925 · Cited by 517
Self-citationRecurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
Fontebasso, A. M., Papillon-Cavanagh, S., Schwartzentruber, J., Nikbakht, H., Gerges, N., Fiset, P.-O., Bechet, D., Faury, D., De Jay, N., Ramkissoon, L. A., et al. (2014) · Nature Genetics · doi:10.1038/ng.2950 · Cited by 465
Elvidge, G. P., Glenny, L., Appelhoff, R. J., Ratcliffe, P. J., Ragoussis, J., & Gleadle, J. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511408200 · Cited by 464
The double face of the histone variant H3.3
Szenker, E., Ray-Gallet, D., & Almouzni, G. (2011) · Cell Research · doi:10.1038/cr.2011.14 · Cited by 391
Buczkowicz, P., Bartels, U., Bouffet, E., Becher, O., & Hawkins, C. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1319-6 · Cited by 350
DNA microarrays identification of primary and secondary target genes regulated by p53
Kannan, K., Amariglio, N., Rechavi, G., Jakob-Hirsch, J., Kela, I., Kaminski, N., Getz, G., Domany, E., & Givol, D. (2001) · Oncogene · doi:10.1038/sj.onc.1204319 · Cited by 331
Paugh, B. S., Broniscer, A., Qu, C., Miller, C. P., Zhang, J., Tatevossian, R. G., Olson, J. M., Geyer, J. R., Chi, S. N., da Silva, N. S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5677 · Cited by 320
Cromer, A., Carles, A., Millon, R., Ganguli, G., Chalmel, F., Lemaire, F., Young, J., Dembélé, D., Thibault, C., Muller, D., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207345 · Cited by 273
Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme
Zinn, P. O., Majadan, B., Sathyan, P., Singh, S. K., Majumder, S., Jolesz, F. A., & Colen, R. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025451 · Cited by 265
Puget, S., Philippe, C., Bax, D. A., Job, B., Varlet, P., Junier, M.-P., Andreiuolo, F., Carvalho, D., Reis, R., Guerrini-Rousseau, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030313 · Cited by 242
Self-citationFinzsch, M., Stolt, C. C., Lommes, P., & Wegner, M. (2008) · Development · doi:10.1242/dev.010454 · Cited by 235
RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.
Gildea, J. J., Seraj, M. J., Oxford, G., Harding, M. A., Hampton, G. M., Moskaluk, C. A., Frierson, H. F., Conaway, M. R., & Theodorescu, D. (2002) · PubMed · Cited by 233
Jansen, M. H., Veldhuijzen van Zanten, S. E., Sanchez Aliaga, E., Heymans, M. W., Warmuth-Metz, M., Hargrave, D., van der Hoeven, E. J., Gidding, C. E., de Bont, E. S., Eshghi, O. S., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou104 · Cited by 200
Lu, C., Bonome, T., Li, Y., Kamat, A. A., Han, L. Y., Schmandt, R., Coleman, R. L., Gershenson, D. M., Jaffe, R. B., Birrer, M. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3700 · Cited by 182
Leonard, M. O., Cottell, D. C., Godson, C., Brady, H. R., & Taylor, C. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302560200 · Cited by 169
Ion channels and tranporters in cancer. 2. Ion channels and the control of cancer cell migration
Cuddapah, V. A., & Sontheimer, H. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00102.2011 · Cited by 164
A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas
Bax, D. A., Mackay, A. G., Little, S. E., Carvalho, D. M., Viana‐Pereira, M., Tamber, N., Grigoriadis, A. E., Ashworth, A., Reis, R. M., Ellison, D. W., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0438 · Cited by 160
Self-citationRickman, D. S., Millon, R., de Reyniès, A., Thomas, E., Wasylyk, C., Müller, D., Abecassis, J., & Wasylyk, B. (2008) · Oncogene · doi:10.1038/onc.2008.251 · Cited by 153
IDH1andIDH2Mutations in Gliomas
Carli, E. D., Wang, X.-W., & Puget, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmc090593 · Cited by 142
Self-citationInhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 Reduces Glioma Invasion
Haas, B. R., & Sontheimer, H. W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4666 · Cited by 135
Pollack, I. F., Stewart, C. F., Koçak, M., Poussaint, T. Y., Broniscer, A., Banerjee, A., Douglas, J. G., Kun, L. E., Boyett, J. M., & Geyer, J. R. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq199 · Cited by 131
Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma
Grill, J., Puget, S., Andreiuolo, F. D. M., Philippe, C., MacConaill, L. E., & Kieran, M. W. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.24060 · Cited by 130
Self-citationMense, S. M., Sengupta, A., Zhou, M., Lan, C., Bentsman, G., Volsky, D. J., & Li, Z. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00315.2005 · Cited by 130
Provenzani, A., Fronza, R., Loreni, F., Pascale, A., Amadio, M., & Quattrone, A. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi377 · Cited by 120
Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma
Hargrave, D. R., Chuang, N. A., & Bouffet, É. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9473-5 · Cited by 108
Nakamura, T., Fidler, I. J., & Coombes, K. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2563 · Cited by 93
Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells
Bouvier, C., Bartoli, C., Aguirre‐Cruz, L., Virard, I., Colin, C., Fernandez, C., Gouvernet, J., & Figarella‐Branger, D. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.2.0344 · Cited by 91
Genomic aberrations in pediatric diffuse intrinsic pontine gliomas
Warren, K. E., Killian, K. J., Suuriniemi, M., Wang, Y., Quezado, M., & Meltzer, P. S. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor190 · Cited by 86
Ion channels and transporters in metastasis
Stock, C. M., & Schwab, A. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.11.012 · Cited by 82
Normalization of Microarray Data: Single-labeled and Dual-labeled Arrays
Do, J. H., & Choi, D. (2006) · Molecules and Cells · doi:10.1016/s1016-8478(23)17418-8 · Cited by 80
Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas
Riemenschneider, M. J., Koy, T. H., & Reifenberger, G. (2004) · Acta Neuropathologica · doi:10.1007/s00401-003-0809-8 · Cited by 67
Kwee, T. C., Galbán, C. J., Tsien, C. I., Junck, L., Sundgren, P. C., Ivancevic, M. K., Johnson, T. D., Meyer, C. R., Rehemtulla, A., Ross, B. D., et al. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22070 · Cited by 66
Bidus, M. A., Risinger, J. I., Chandramouli, G. V. R., Dainty, L. A., Litzi, T. J., Berchuck, A., Barrett, J. C., & Maxwell, G. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0835 · Cited by 65
A Genetic Approach to the Recruitment of PRC2 at the HoxD Locus
Schorderet, P., Lonfat, N., Darbellay, F., Tschopp, P., Gitto, S., Soshnikova, N. V., & Duboule, D. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003951 · Cited by 34
Research works printed but not linked: 4
- Albright AL, Packer RJ, Zimmerman R et al (1993) Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery 33:1026–1029 (discussion 1029–1030) · doi:10.1227/00006123-199312000-00010
- Chassot A, Canale S, Varlet P et al (2012) Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. J Neurooncol 106:399–407. doi: 10.1007/s11060-011-0681-7 · doi:10.1007/s11060-011-0681-7
- Poussaint TY, Kocak M, Vajapeyam S et al (2011) MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro-Oncol 13:417–427. doi: 10.1093/neuonc/noq200 · doi:10.1093/neuonc/noq200
- Puget S, Blauwblomme T, Grill J (2012) Is biopsy safe in children with newly diagnosed diffuse intrinsic pontine glioma? Am Soc Clin Oncol Educ Book ASCO Am Soc Clin Oncol Meet. doi: 10.14694/EdBook_AM.2012.32.629 · doi:10.14694/edbook_am.2012.32.629
Cited by
Primary brain tumours in adults
Lapointe, S., Perry, A., & Butowski, N. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30990-5 · Cited by 1,366
Mackay, A., Burford, A., Carvalho, D., Izquierdo, E., Fazal-Salom, J., Taylor, K. R., Bjerke, L., Clarke, M., Vinci, M., Nandhabalan, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.017 · Cited by 1,212
Self-citationWHO 2016 Classification of gliomas
Wesseling, P., & Capper, D. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12432 · Cited by 795
Advances in the molecular genetics of gliomas — implications for classification and therapy
Reifenberger, G., Wirsching, H.-G., Knobbe-Thomsen, C. B., & Weller, M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.204 · Cited by 662
Weller, M., Wen, P. Y., Chang, S. M., Dirven, L., Lim, M., Monje, M., & Reifenberger, G. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00516-y · Cited by 592
Metadata
- Authors
- Castel, D., Philippe, C., Calmon, R., Le Dret, L., Truffaux, N., Boddaert, N., Pagès, M., Taylor, K. R., Saulnier, P., Lacroix, L., Mackay, A., Jones, C., Sainte-Rose, C., Blauwblomme, T., Andreiuolo, F., Puget, S., Grill, J., Varlet, P., & Debily, M.-A.
- Venue
- Acta Neuropathologica
- Published
- 2015-09-23
- Volume
- 130
- Issue
- 6
- Pages
- 815-827
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2101775250
- Cited by
- 664
- References
- 58
- FWCI
- 23.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- Programme PICRI 2011 "Partenariats Institution Citoyens pour le Recherche et l'Innovation"
- Agence Nationale de la Recherche (FR) (Programme "Brainomics")
- Charities "Etoile de Martin", "Défi de Fortunée", "Lemos Family and Friends".
- Association pour la Recherche en Neurochirurgie Pédiatrique
- NHS funding to the National Institute of Health Research Biomedical Research (GB)
- Charity "Abbie’s Army"
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.